Cochrane Abstracts
Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Amfetamine for Attention Deficit Hyperactivity Disorder in People With Intellectual Disabilities." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431770/all/Amfetamine_for_attention_deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities.
Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431770/all/Amfetamine_for_attention_deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities. Accessed April 26, 2025.
Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431770/all/Amfetamine_for_attention_deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities
Amfetamine for Attention Deficit Hyperactivity Disorder in People With Intellectual Disabilities [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431770/all/Amfetamine_for_attention_deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities
ID - 431770
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431770/all/Amfetamine_for_attention_deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
